Biomarkers in Prostate Cancer Diagnosis: From Current Knowledge to the Role of Metabolomics and Exosomes

Biomarkers in Prostate Cancer Diagnosis: From Current Knowledge to the Role of Metabolomics and Exosomes

Early detection of prostate cancer (PC) is largely carried out using assessment of prostate-specific antigen (PSA) level; yet it cannot reliably discriminate between benign pathologies and clinically significant forms of PC. To overcome the current limitations of PSA, new urinary and serum biomarker...

Full description

Bibliographic Details
Main Authors: Stefano Salciccia, Anna Laura Capriotti, Aldo Laganà, Stefano Fais, Mariantonia Logozzi, Ettore De Berardinis, Gian Maria Busetto, Giovanni Battista Di Pierro, Gian Piero Ricciuti, Francesco Del Giudice, Alessandro Sciarra, Peter R. Carroll, Matthew R. Cooperberg, Beatrice Sciarra, Martina Maggi
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:International Journal of Molecular Sciences
Subjects:
prostate cancer
biomarkers
metabolomics
exosomes
early diagnosis
Online Access:https://www.mdpi.com/1422-0067/22/9/4367

Internet

https://www.mdpi.com/1422-0067/22/9/4367

Similar Items